Pre-operative prognostic nutritional index predicts the outcomes for triple-negative breast cancer

Tumor Biology

Volumn 35, Issue 12, 2014, Pages 12165-12171

  Yang, Zhengjun ^a,b   Zhang, Bin ^a,b   Hou, Likun ^a,b   Xie, Yegong ^a,b   Cao, Xuchen ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

Prognosis; Prognostic nutritional index; Survival; Triple negative breast cancer

Indexed keywords

ALBUMIN; CARBOHYDRATE ANTIGEN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ADJUVANT THERAPY; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DISTANT METASTASIS; ECHOMAMMOGRAPHY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNITY; LONG TERM SURVIVAL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MASTECTOMY; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSTIC NUTRITIONAL INDEX; RETROSPECTIVE STUDY; TRIPLE NEGATIVE BREAST CANCER; CANCER GRADING; CANCER STAGING; FEMALE; METASTASIS; MIDDLE AGED; MORTALITY; PREOPERATIVE PERIOD; PROGNOSIS; RISK FACTOR; TRIPLE NEGATIVE BREAST NEOPLASMS;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; NUTRITIONAL STATUS; PATIENT OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84925283344     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2524-6     Document Type: Article

References (29)

1. Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L, et al. The incidences and mortalities of major cancers in china, 2009. Chin J Cancer. 2013;32:106–12.
2. Curigliano G, Goldhirsch A. The triple-negative subtype: new ideas for the poorest prognosis breast cancer. J Natl Cancer Inst Monogr. 2011;2011:108–10.
3. Brady-West DC, McGrowder DA. Triple negative breast cancer: therapeutic and prognostic implications. Asian Pac J Cancer Prev. 2011;12:2139–43.
4. Kim HR, Jung KH, Im SA, Im YH, Kang SY, Park KH, et al. Multicentre phase ii trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (kcsg br-0905). Ann Oncol. 2013;24:1485–90.
5. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the carolina breast cancer study. JAMA. 2006;295:2492–502.
6. Azab BN, Bhatt VR, Vonfrolio S, Bachir R, Rubinshteyn V, Alkaied H, et al. Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients. Am J Surg. 2013;206:764–70.
7. Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.
8. Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009;69:5383–91.
9. Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–5.
10. Hubbard TJ, Lawson-McLean A, Fearon KC. Nutritional predictors of postoperative outcome in pancreatic cancer (br j surg 2011; 98: 268–274). Br J Surg. 2011;98:1032. author reply 1032–1033.
11. Nozoe T, Kohno M, Iguchi T, Mori E, Maeda T, Matsukuma A, et al. The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today. 2012;42:532–5.
12. Pinato DJ, North BV, Sharma R. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (pni). Br J Cancer. 2012;106:1439–45.
13. Yao ZH, Tian GY, Wan YY, Kang YM, Guo HS, Liu QH, et al. Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma. J Cancer Res Clin Oncol. 2013;139:2117–23.
14. Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, Enomoto K, et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol. 2013;20:2647–54.
15. Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670–5.
16. Barreto Penie J, Cuban Group for the Study of Hospital M. State of malnutrition in cuban hospitals. Nutrition. 2005;21:487–97.
17. Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003;32:201–15.
18. Schiesser M, Kirchhoff P, Muller MK, Schafer M, Clavien PA. The correlation of nutrition risk index, nutrition risk score, and bioimpedance analysis with postoperative complications in patients undergoing gastrointestinal surgery. Surgery. 2009;145:519–26.
19. Alvares-da-Silva MR, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition. 2005;21:113–7.
20. Beto JA, Bansal VK, Hart J, McCarthy M, Roberts D. Hemodialysis prognostic nutrition index as a predictor for morbidity and mortality in hemodialysis patients and its correlation to adequacy of dialysis. Council on renal nutrition national research question collaborative study group. J Ren Nutr. 1999;9:2–8.
21. Paillaud E, Liuu E, Laurent M, Le Thuaut A, Vincent H, Raynaud-Simon A, et al. Geriatric syndromes increased the nutritional risk in elderly cancer patients independently from tumoursite and metastatic status. The elcapa-05 cohort study. Clin Nutr. 2014;33:330–5.
22. Onate-Ocana LF, Aiello-Crocifoglio V, Gallardo-Rincon D, Herrera-Goepfert R, Brom-Valladares R, Carrillo JF, et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol. 2007;14:381–9.
23. Lai CC, You JF, Yeh CY, Chen JS, Tang R, Wang JY, et al. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis. 2011;26:473–81.
24. Lis C, Grutsch J, Vashi P, Lammersfeld C. Is serum albumin an independent predictor of survival in patients with breast cancer? J Parenter Enter Nutr. 2003;27:10–5.
25. Laursen I, Briand P, Lykkesfeldt AE. Serum albumin as a modulator on growth of the human breast cancer cell line, mcf-7. Anticancer Res. 1990;10:343–51.
26. Mainous MR, Deitch EA. Nutrition and infection. Surg Clin North Am. 1994;74:659–76.
27. Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, Davoli C, et al. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas. 2006;32:22–8.
28. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73:215–20.
29. Loi S, Michiels S, Salgado R, Sirtaine N, Jose V, Fumagalli D, et al. Tumor infiltrating lymphocytes is prognostic and predictive for trastuzumab benefit in early breast cancer: results from the finher trial. Ann Oncol. 2014.